Movesense Medical is a wearable sensor intended for measuring single-channel ECG, heart rate, heart rate variability, and human motion. Credit: Shutterstock/Jackie Niam.

Movesense has announced its wearable Movesense Medical electrocardiogram (ECG) and movement sensor has been certified as a Class IIa medical device in conformity with the European Medical Device Regulation 2017/745 (MDR).

The EU Medical Device Regulation 2017/745 (MDR) replaced the Medical Device Directive MDD 93/42/EEC in 2017, with all existing devices having to transition from the MDD to the MDR by May 2024.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

According to the Finland-based company, Movesense Medical has become the first MDR-certified chest strap ECG and heart rate monitor. The change in regulatory conformation will see Movesense move from solely a distributor to also a manufacturer, taking over from its previous owner Suunto.

Movesense Medical is a wearable sensor intended for measuring single-channel ECG, heart rate, heart rate variability, and human motion. With the ability to transfer data wirelessly, the sensor has applications in remote patient monitoring and telehealth. It also offers programmability to be tailored to specific applications such as running custom algorithms and sending measured signals to other devices for visualisation.

According to forecasts by GlobalData, the wearable technology global market will be worth $156bn by 2024. The device taps into the growing market of wearable tech in medical and healthcare settings. GlobalData analysis suggests that this sector will become more lucrative as global populations age, and wearables become an increasingly important aspect of healthcare provision.

GlobalData medical analyst Shane Dibblee says: “Wearable devices are useful tools for users to track personal trends and initiate conversations with a healthcare provider. This market is expected to continue to grow in the near future as new features and useful sensors are added. However, any test result or evaluation will still need to be confirmed by a medical professional for the foreseeable future.”